Erlotinib Withdrawn Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01432119Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib